Literature DB >> 18344320

Immunization by a bacterial aerosol.

Lucila Garcia-Contreras1, Yun-Ling Wong, Pavan Muttil, Danielle Padilla, Jerry Sadoff, Jessica Derousse, Willem Andreas Germishuizen, Sunali Goonesekera, Katharina Elbert, Barry R Bloom, Rich Miller, P Bernard Fourie, Anthony Hickey, David Edwards.   

Abstract

By manufacturing a single-particle system in two particulate forms (i.e., micrometer size and nanometer size), we have designed a bacterial vaccine form that exhibits improved efficacy of immunization. Microstructural properties are adapted to alter dispersive and aerosol properties independently. Dried "nanomicroparticle" vaccines possess two axes of nanoscale dimensions and a third axis of micrometer dimension; the last one permits effective micrometer-like physical dispersion, and the former provides alignment of the principal nanodimension particle axes with the direction of airflow. Particles formed with this combination of nano- and micrometer-scale dimensions possess a greater ability to aerosolize than particles of standard spherical isotropic shape and of similar geometric diameter. Here, we demonstrate effective application of this biomaterial by using the live attenuated tuberculosis vaccine bacille Calmette-Guérin (BCG). Prepared as a spray-dried nanomicroparticle aerosol, BCG vaccine exhibited high-efficiency delivery and peripheral lung targeting capacity from a low-cost and technically simple delivery system. Aerosol delivery of the BCG nanomicroparticle to normal guinea pigs subsequently challenged with virulent Mycobacterium tuberculosis significantly reduced bacterial burden and lung pathology both relative to untreated animals and to control animals immunized with the standard parenteral BCG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344320      PMCID: PMC2290758          DOI: 10.1073/pnas.0800043105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Descriptors of irregular particle morphology and powder properties.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-06-09       Impact factor: 15.470

Review 2.  Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.

Authors:  Timothy M Crowder; Jacky A Rosati; Jeffry D Schroeter; Anthony J Hickey; Ted B Martonen
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

Review 3.  Pulmonary vaccine delivery.

Authors:  Dongmei Lu; Anthony J Hickey
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

4.  The influence of fibre shape in lung deposition-mathematical estimates.

Authors:  R L Harris; V Timbrell
Journal:  Inhaled Part       Date:  1975-09

5.  Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols.

Authors:  K A Fults; I F Miller; A J Hickey
Journal:  Pharm Dev Technol       Date:  1997-02       Impact factor: 3.133

6.  Large porous particles for pulmonary drug delivery.

Authors:  D A Edwards; J Hanes; G Caponetti; J Hrkach; A Ben-Jebria; M L Eskew; J Mintzes; D Deaver; N Lotan; R Langer
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

7.  Aerogenic BCG vaccination against tuberculosis in animal and human subjects.

Authors:  S R Rosenthal; J T McEnery; N Raisys
Journal:  J Asthma Res       Date:  1968-06

8.  BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route.

Authors:  M Lagranderie; P Ravisse; G Marchal; M Gheorghiu; V Balasubramanian; E H Weigeshaus; D W Smith
Journal:  Tuber Lung Dis       Date:  1993-02

Review 9.  Immunology of tuberculosis and implications in vaccine development.

Authors:  JoAnne L Flynn
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

Review 10.  Pulmonary DNA vaccination: concepts, possibilities and perspectives.

Authors:  Maytal Bivas-Benita; Tom H M Ottenhoff; Hans E Junginger; Gerrit Borchard
Journal:  J Control Release       Date:  2005-09-20       Impact factor: 9.776

View more
  41 in total

1.  Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.

Authors:  Pavan Muttil; Brian Pulliam; Lucila Garcia-Contreras; John Kevin Fallon; Chenchen Wang; Anthony James Hickey; David A Edwards
Journal:  AAPS J       Date:  2010-09-28       Impact factor: 4.009

2.  Formulation and stabilization of Francisella tularensis live vaccine strain.

Authors:  Satoshi Ohtake; Russell A Martin; Atul Saxena; David Lechuga-Ballesteros; Araceli E Santiago; Eileen M Barry; Vu Truong-Le
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

3.  Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Authors:  Patricia A Darrah; Diane L Bolton; Andrew A Lackner; Deepak Kaushal; Pyone Pyone Aye; Smriti Mehra; James L Blanchard; Peter J Didier; Chad J Roy; Srinivas S Rao; David A Hokey; Charles A Scanga; Donata R Sizemore; Jerald C Sadoff; Mario Roederer; Robert A Seder
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

4.  Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9.

Authors:  Nitesh K Kunda; Julianne Peabody; Lukai Zhai; Dominique N Price; Bryce Chackerian; Ebenezer Tumban; Pavan Muttil
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

Review 5.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

Review 6.  Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Authors:  Nitesh K Kunda; Satyanarayana Somavarapu; Stephen B Gordon; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

Review 7.  Intranasal immunization with dry powder vaccines.

Authors:  Tania F Bahamondez-Canas; Zhengrong Cui
Journal:  Eur J Pharm Biopharm       Date:  2017-11-06       Impact factor: 5.571

8.  Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.

Authors:  Sugandha Saboo; Ebenezer Tumban; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian; Pavan Muttil
Journal:  Mol Pharm       Date:  2016-04-11       Impact factor: 4.939

9.  Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.

Authors:  Chenchen Wang; Pavan Muttil; Dongmei Lu; Adela Ayulia Beltran-Torres; Lucila Garcia-Contreras; Anthony J Hickey
Journal:  AAPS J       Date:  2009-03-10       Impact factor: 4.009

Review 10.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.